After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast enough to save the sick?

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A man who was told he wouldn't live beyond 18 came to terms with the idea of never getting to live out his dreams, but ...

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...

Cystic fibrosis is a genetic disorder that affects roughly 40,000 Americans. The condition is caused by a mutation in the patient's cystic fibrosis transmembrane conductance regulator (CFTR) gene, ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.

Patients with cystic fibrosis (CF) who did not receive a lung transplant developed cardiovascular disease, kidney problems, and cancer at higher rates than those without CF. Those with CF who did ...